Immuno-Biological Laboratories Co., Ltd. (4570)
Market Open
7 Aug, 06:00
JPX JPX Primary ¥
940. 00
-12
-1.2605%
¥
29.06B Market Cap
- P/E Ratio
7.5% Div Yield
113,700 Volume
- Eps
¥ 952
Previous Close Want to track 4570 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immuno-Biological Laboratories Co., Ltd. (4570) Statistics
Valuation metrics
Market Cap 29.06B
Enterprise value 7.94B
Trailing P/E (ttm) 26.61
Forward P/E -
PEG ratio 0.83
Price/Sales (ttm) 8.71
Price/Book (mrq) 4.75
Enterprise Value/Revenue 7.9
Enterprise Value/EBITDA 25.77
Overview
Shares outstanding 9.31M
Float 7.51M
Shares short -
% Held by insiders 0.19%
% Held by institutions 0.04%
Average volume (10 days) 75.95K
Average volume (90 days) 112.9K
Price summary
52-Week low 464
52-Week high 3,820
Beta 0.02
50-Day moving average 966
200-Day moving average 1,277.17
Dividends and splits
Forward annual dividend rate 7.5
Forward annual dividend yield 0.0063%
Trailing annual dividend rate 6
Trailing annual dividend yield 0.0064%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 10:1
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin 0.33%
Operating margin 0.28%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.19%
Income Statement
Revenue (ttm) 1B
Revenue per share (ttm) 107.91
Quarterly revenue growth (yoy) -0.09%
Gross profit (ttm) 706M
EBITDA 226.16M
Net income to common (ttm) 329M
Diluted EPS (ttm) 35.33
Quarterly earnings growth (yoy) -0.3%
Balance Sheet
Total cash (mrq) 989M
Total cash per share (mrq) 106.25
Total debt (mrq) 176M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 5.68%
Book value per share (mrq) 197.94
Cash Flow
Cash flow statement 301M
Levered free cash flow (LFCF) 151M
